GENO — Genovis AB Balance Sheet
0.000.00%
- SEK1.36bn
- SEK1.28bn
- SEK130.36m
Annual balance sheet for Genovis AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 44.1 | 81.3 | 72.8 | 123 | 169 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12.2 | 12.8 | 18.6 | 16.9 | 20.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 72.1 | 109 | 107 | 159 | 208 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.5 | 9.6 | 15.8 | 95.3 | 89.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 107 | 142 | 151 | 289 | 327 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.7 | 24.2 | 18 | 21.2 | 28.2 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 19.5 | 27.8 | 24.9 | 98 | 99.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 87.2 | 114 | 126 | 191 | 228 |
| Total Liabilities & Shareholders' Equity | 107 | 142 | 151 | 289 | 327 |
| Total Common Shares Outstanding |